Becton Dickinson and Company (BDX)vsLeMaitre Vascular Inc (LMAT)
BDX
Becton Dickinson and Company
$177.85
+0.81%
HEALTHCARE · Cap: $48.05B
LMAT
LeMaitre Vascular Inc
$80.59
+2.27%
HEALTHCARE · Cap: $1.82B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 8468% more annual revenue ($22.48B vs $262.43M). LMAT leads profitability with a 25.0% profit margin vs 4.2%. BDX appears more attractively valued with a PEG of 1.11. LMAT earns a higher WallStSmart Score of 62/100 (C+).
BDX
Buy52
out of 100
Grade: C-
LMAT
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.1%
Fair Value
$203.14
Current Price
$177.85
$25.29 discount
Margin of Safety
-55.5%
Fair Value
$56.44
Current Price
$80.59
$24.15 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Keeps 25 of every $100 in revenue as profit
Strong operational efficiency at 29.0%
Earnings expanding 22.6% YoY
Areas to Watch
Premium valuation, high expectations priced in
ROE of 3.9% — below average capital efficiency
4.2% margin — thin
Earnings declined 31.4%
Expensive relative to growth rate
Moderate valuation
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : LMAT
The strongest argument for LMAT centers on Altman Z-Score, Profit Margin, Operating Margin. Profitability is solid with margins at 25.0% and operating margin at 29.0%.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin. Thin 4.2% margins leave little buffer for downturns.
Bear Case : LMAT
The primary concerns for LMAT are PEG Ratio, P/E Ratio, Market Cap.
Key Dynamics to Monitor
BDX profiles as a value stock while LMAT is a mature play — different risk/reward profiles.
LMAT carries more volatility with a beta of 0.49 — expect wider price swings.
LMAT is growing revenue faster at 9.6% — sustainability is the question.
BDX generates stronger free cash flow (509M), providing more financial flexibility.
Bottom Line
LMAT scores higher overall (62/100 vs 52/100), backed by strong 25.0% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →LeMaitre Vascular Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?